Global Drug-Eluting Stents Market Research Report 2024(Status and Outlook)
Report Overview:
A drug eluting stent (DES), also known as a drug-eluting stent, carries a drug through a polymer coated on the surface of a metal stent. When the stent is placed in an intravascular lesion, the drug is coated in the polymer coating. The biological effect is exerted by controlled release to the cardiovascular wall tissue by means of elution. The currently marketed drug-eluting stents include a rapamycin-eluting stent and a paclitaxel-eluting stent, both of which prevent in-stent restenosis by inhibiting smooth proliferation of smooth muscle cells.
The Global Drug-Eluting Stents Market Size was estimated at USD 6202.03 million in 2023 and is projected to reach USD 7623.88 million by 2029, exhibiting a CAGR of 3.50% during the forecast period.
This report provides a deep insight into the global Drug-Eluting Stents market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug-Eluting Stents Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug-Eluting Stents market in any manner.
Global Drug-Eluting Stents Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Boston Scientific
Medtronic, Inc.
Abbott
Lepu Medical
MicroPort Scientific Corporation
Cook Medical
Terumo
Biosensors International
Balton
AlviMedica Medical Technologies
Biotronik
Shandong JW Medical
Sino Medical
Beijing AMSINO
Liaoning Biomedical Materials R&D Center Co.(LBC)
Market Segmentation (by Type)
Rapamycin
Paclitaxel
Everolimus
Others
Market Segmentation (by Application)
Angina Pectoris
Myocardial Infarction
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug-Eluting Stents Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
A drug eluting stent (DES), also known as a drug-eluting stent, carries a drug through a polymer coated on the surface of a metal stent. When the stent is placed in an intravascular lesion, the drug is coated in the polymer coating. The biological effect is exerted by controlled release to the cardiovascular wall tissue by means of elution. The currently marketed drug-eluting stents include a rapamycin-eluting stent and a paclitaxel-eluting stent, both of which prevent in-stent restenosis by inhibiting smooth proliferation of smooth muscle cells.
The Global Drug-Eluting Stents Market Size was estimated at USD 6202.03 million in 2023 and is projected to reach USD 7623.88 million by 2029, exhibiting a CAGR of 3.50% during the forecast period.
This report provides a deep insight into the global Drug-Eluting Stents market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug-Eluting Stents Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug-Eluting Stents market in any manner.
Global Drug-Eluting Stents Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Boston Scientific
Medtronic, Inc.
Abbott
Lepu Medical
MicroPort Scientific Corporation
Cook Medical
Terumo
Biosensors International
Balton
AlviMedica Medical Technologies
Biotronik
Shandong JW Medical
Sino Medical
Beijing AMSINO
Liaoning Biomedical Materials R&D Center Co.(LBC)
Market Segmentation (by Type)
Rapamycin
Paclitaxel
Everolimus
Others
Market Segmentation (by Application)
Angina Pectoris
Myocardial Infarction
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Drug-Eluting Stents Market
- Overview of the regional outlook of the Drug-Eluting Stents Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug-Eluting Stents Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Drug-Eluting Stents
1.2 Key Market Segments
1.2.1 Drug-Eluting Stents Segment by Type
1.2.2 Drug-Eluting Stents Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUG-ELUTING STENTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Drug-Eluting Stents Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Drug-Eluting Stents Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUG-ELUTING STENTS MARKET COMPETITIVE LANDSCAPE
3.1 Global Drug-Eluting Stents Sales by Manufacturers (2019-2024)
3.2 Global Drug-Eluting Stents Revenue Market Share by Manufacturers (2019-2024)
3.3 Drug-Eluting Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Drug-Eluting Stents Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Drug-Eluting Stents Sales Sites, Area Served, Product Type
3.6 Drug-Eluting Stents Market Competitive Situation and Trends
3.6.1 Drug-Eluting Stents Market Concentration Rate
3.6.2 Global 5 and 10 Largest Drug-Eluting Stents Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 DRUG-ELUTING STENTS INDUSTRY CHAIN ANALYSIS
4.1 Drug-Eluting Stents Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUG-ELUTING STENTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 DRUG-ELUTING STENTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug-Eluting Stents Sales Market Share by Type (2019-2024)
6.3 Global Drug-Eluting Stents Market Size Market Share by Type (2019-2024)
6.4 Global Drug-Eluting Stents Price by Type (2019-2024)
7 DRUG-ELUTING STENTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug-Eluting Stents Market Sales by Application (2019-2024)
7.3 Global Drug-Eluting Stents Market Size (M USD) by Application (2019-2024)
7.4 Global Drug-Eluting Stents Sales Growth Rate by Application (2019-2024)
8 DRUG-ELUTING STENTS MARKET SEGMENTATION BY REGION
8.1 Global Drug-Eluting Stents Sales by Region
8.1.1 Global Drug-Eluting Stents Sales by Region
8.1.2 Global Drug-Eluting Stents Sales Market Share by Region
8.2 North America
8.2.1 North America Drug-Eluting Stents Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drug-Eluting Stents Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Drug-Eluting Stents Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drug-Eluting Stents Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drug-Eluting Stents Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Boston Scientific
9.1.1 Boston Scientific Drug-Eluting Stents Basic Information
9.1.2 Boston Scientific Drug-Eluting Stents Product Overview
9.1.3 Boston Scientific Drug-Eluting Stents Product Market Performance
9.1.4 Boston Scientific Business Overview
9.1.5 Boston Scientific Drug-Eluting Stents SWOT Analysis
9.1.6 Boston Scientific Recent Developments
9.2 Medtronic, Inc.
9.2.1 Medtronic, Inc. Drug-Eluting Stents Basic Information
9.2.2 Medtronic, Inc. Drug-Eluting Stents Product Overview
9.2.3 Medtronic, Inc. Drug-Eluting Stents Product Market Performance
9.2.4 Medtronic, Inc. Business Overview
9.2.5 Medtronic, Inc. Drug-Eluting Stents SWOT Analysis
9.2.6 Medtronic, Inc. Recent Developments
9.3 Abbott
9.3.1 Abbott Drug-Eluting Stents Basic Information
9.3.2 Abbott Drug-Eluting Stents Product Overview
9.3.3 Abbott Drug-Eluting Stents Product Market Performance
9.3.4 Abbott Drug-Eluting Stents SWOT Analysis
9.3.5 Abbott Business Overview
9.3.6 Abbott Recent Developments
9.4 Lepu Medical
9.4.1 Lepu Medical Drug-Eluting Stents Basic Information
9.4.2 Lepu Medical Drug-Eluting Stents Product Overview
9.4.3 Lepu Medical Drug-Eluting Stents Product Market Performance
9.4.4 Lepu Medical Business Overview
9.4.5 Lepu Medical Recent Developments
9.5 MicroPort Scientific Corporation
9.5.1 MicroPort Scientific Corporation Drug-Eluting Stents Basic Information
9.5.2 MicroPort Scientific Corporation Drug-Eluting Stents Product Overview
9.5.3 MicroPort Scientific Corporation Drug-Eluting Stents Product Market Performance
9.5.4 MicroPort Scientific Corporation Business Overview
9.5.5 MicroPort Scientific Corporation Recent Developments
9.6 Cook Medical
9.6.1 Cook Medical Drug-Eluting Stents Basic Information
9.6.2 Cook Medical Drug-Eluting Stents Product Overview
9.6.3 Cook Medical Drug-Eluting Stents Product Market Performance
9.6.4 Cook Medical Business Overview
9.6.5 Cook Medical Recent Developments
9.7 Terumo
9.7.1 Terumo Drug-Eluting Stents Basic Information
9.7.2 Terumo Drug-Eluting Stents Product Overview
9.7.3 Terumo Drug-Eluting Stents Product Market Performance
9.7.4 Terumo Business Overview
9.7.5 Terumo Recent Developments
9.8 Biosensors International
9.8.1 Biosensors International Drug-Eluting Stents Basic Information
9.8.2 Biosensors International Drug-Eluting Stents Product Overview
9.8.3 Biosensors International Drug-Eluting Stents Product Market Performance
9.8.4 Biosensors International Business Overview
9.8.5 Biosensors International Recent Developments
9.9 Balton
9.9.1 Balton Drug-Eluting Stents Basic Information
9.9.2 Balton Drug-Eluting Stents Product Overview
9.9.3 Balton Drug-Eluting Stents Product Market Performance
9.9.4 Balton Business Overview
9.9.5 Balton Recent Developments
9.10 AlviMedica Medical Technologies
9.10.1 AlviMedica Medical Technologies Drug-Eluting Stents Basic Information
9.10.2 AlviMedica Medical Technologies Drug-Eluting Stents Product Overview
9.10.3 AlviMedica Medical Technologies Drug-Eluting Stents Product Market Performance
9.10.4 AlviMedica Medical Technologies Business Overview
9.10.5 AlviMedica Medical Technologies Recent Developments
9.11 Biotronik
9.11.1 Biotronik Drug-Eluting Stents Basic Information
9.11.2 Biotronik Drug-Eluting Stents Product Overview
9.11.3 Biotronik Drug-Eluting Stents Product Market Performance
9.11.4 Biotronik Business Overview
9.11.5 Biotronik Recent Developments
9.12 Shandong JW Medical
9.12.1 Shandong JW Medical Drug-Eluting Stents Basic Information
9.12.2 Shandong JW Medical Drug-Eluting Stents Product Overview
9.12.3 Shandong JW Medical Drug-Eluting Stents Product Market Performance
9.12.4 Shandong JW Medical Business Overview
9.12.5 Shandong JW Medical Recent Developments
9.13 Sino Medical
9.13.1 Sino Medical Drug-Eluting Stents Basic Information
9.13.2 Sino Medical Drug-Eluting Stents Product Overview
9.13.3 Sino Medical Drug-Eluting Stents Product Market Performance
9.13.4 Sino Medical Business Overview
9.13.5 Sino Medical Recent Developments
9.14 Beijing AMSINO
9.14.1 Beijing AMSINO Drug-Eluting Stents Basic Information
9.14.2 Beijing AMSINO Drug-Eluting Stents Product Overview
9.14.3 Beijing AMSINO Drug-Eluting Stents Product Market Performance
9.14.4 Beijing AMSINO Business Overview
9.14.5 Beijing AMSINO Recent Developments
9.15 Liaoning Biomedical Materials RandD Center Co.(LBC)
9.15.1 Liaoning Biomedical Materials RandD Center Co.(LBC) Drug-Eluting Stents Basic Information
9.15.2 Liaoning Biomedical Materials RandD Center Co.(LBC) Drug-Eluting Stents Product Overview
9.15.3 Liaoning Biomedical Materials RandD Center Co.(LBC) Drug-Eluting Stents Product Market Performance
9.15.4 Liaoning Biomedical Materials RandD Center Co.(LBC) Business Overview
9.15.5 Liaoning Biomedical Materials RandD Center Co.(LBC) Recent Developments
10 DRUG-ELUTING STENTS MARKET FORECAST BY REGION
10.1 Global Drug-Eluting Stents Market Size Forecast
10.2 Global Drug-Eluting Stents Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Drug-Eluting Stents Market Size Forecast by Country
10.2.3 Asia Pacific Drug-Eluting Stents Market Size Forecast by Region
10.2.4 South America Drug-Eluting Stents Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Drug-Eluting Stents by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Drug-Eluting Stents Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Drug-Eluting Stents by Type (2025-2030)
11.1.2 Global Drug-Eluting Stents Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Drug-Eluting Stents by Type (2025-2030)
11.2 Global Drug-Eluting Stents Market Forecast by Application (2025-2030)
11.2.1 Global Drug-Eluting Stents Sales (K Units) Forecast by Application
11.2.2 Global Drug-Eluting Stents Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Drug-Eluting Stents
1.2 Key Market Segments
1.2.1 Drug-Eluting Stents Segment by Type
1.2.2 Drug-Eluting Stents Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUG-ELUTING STENTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Drug-Eluting Stents Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Drug-Eluting Stents Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUG-ELUTING STENTS MARKET COMPETITIVE LANDSCAPE
3.1 Global Drug-Eluting Stents Sales by Manufacturers (2019-2024)
3.2 Global Drug-Eluting Stents Revenue Market Share by Manufacturers (2019-2024)
3.3 Drug-Eluting Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Drug-Eluting Stents Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Drug-Eluting Stents Sales Sites, Area Served, Product Type
3.6 Drug-Eluting Stents Market Competitive Situation and Trends
3.6.1 Drug-Eluting Stents Market Concentration Rate
3.6.2 Global 5 and 10 Largest Drug-Eluting Stents Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 DRUG-ELUTING STENTS INDUSTRY CHAIN ANALYSIS
4.1 Drug-Eluting Stents Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUG-ELUTING STENTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 DRUG-ELUTING STENTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug-Eluting Stents Sales Market Share by Type (2019-2024)
6.3 Global Drug-Eluting Stents Market Size Market Share by Type (2019-2024)
6.4 Global Drug-Eluting Stents Price by Type (2019-2024)
7 DRUG-ELUTING STENTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug-Eluting Stents Market Sales by Application (2019-2024)
7.3 Global Drug-Eluting Stents Market Size (M USD) by Application (2019-2024)
7.4 Global Drug-Eluting Stents Sales Growth Rate by Application (2019-2024)
8 DRUG-ELUTING STENTS MARKET SEGMENTATION BY REGION
8.1 Global Drug-Eluting Stents Sales by Region
8.1.1 Global Drug-Eluting Stents Sales by Region
8.1.2 Global Drug-Eluting Stents Sales Market Share by Region
8.2 North America
8.2.1 North America Drug-Eluting Stents Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drug-Eluting Stents Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Drug-Eluting Stents Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drug-Eluting Stents Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drug-Eluting Stents Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Boston Scientific
9.1.1 Boston Scientific Drug-Eluting Stents Basic Information
9.1.2 Boston Scientific Drug-Eluting Stents Product Overview
9.1.3 Boston Scientific Drug-Eluting Stents Product Market Performance
9.1.4 Boston Scientific Business Overview
9.1.5 Boston Scientific Drug-Eluting Stents SWOT Analysis
9.1.6 Boston Scientific Recent Developments
9.2 Medtronic, Inc.
9.2.1 Medtronic, Inc. Drug-Eluting Stents Basic Information
9.2.2 Medtronic, Inc. Drug-Eluting Stents Product Overview
9.2.3 Medtronic, Inc. Drug-Eluting Stents Product Market Performance
9.2.4 Medtronic, Inc. Business Overview
9.2.5 Medtronic, Inc. Drug-Eluting Stents SWOT Analysis
9.2.6 Medtronic, Inc. Recent Developments
9.3 Abbott
9.3.1 Abbott Drug-Eluting Stents Basic Information
9.3.2 Abbott Drug-Eluting Stents Product Overview
9.3.3 Abbott Drug-Eluting Stents Product Market Performance
9.3.4 Abbott Drug-Eluting Stents SWOT Analysis
9.3.5 Abbott Business Overview
9.3.6 Abbott Recent Developments
9.4 Lepu Medical
9.4.1 Lepu Medical Drug-Eluting Stents Basic Information
9.4.2 Lepu Medical Drug-Eluting Stents Product Overview
9.4.3 Lepu Medical Drug-Eluting Stents Product Market Performance
9.4.4 Lepu Medical Business Overview
9.4.5 Lepu Medical Recent Developments
9.5 MicroPort Scientific Corporation
9.5.1 MicroPort Scientific Corporation Drug-Eluting Stents Basic Information
9.5.2 MicroPort Scientific Corporation Drug-Eluting Stents Product Overview
9.5.3 MicroPort Scientific Corporation Drug-Eluting Stents Product Market Performance
9.5.4 MicroPort Scientific Corporation Business Overview
9.5.5 MicroPort Scientific Corporation Recent Developments
9.6 Cook Medical
9.6.1 Cook Medical Drug-Eluting Stents Basic Information
9.6.2 Cook Medical Drug-Eluting Stents Product Overview
9.6.3 Cook Medical Drug-Eluting Stents Product Market Performance
9.6.4 Cook Medical Business Overview
9.6.5 Cook Medical Recent Developments
9.7 Terumo
9.7.1 Terumo Drug-Eluting Stents Basic Information
9.7.2 Terumo Drug-Eluting Stents Product Overview
9.7.3 Terumo Drug-Eluting Stents Product Market Performance
9.7.4 Terumo Business Overview
9.7.5 Terumo Recent Developments
9.8 Biosensors International
9.8.1 Biosensors International Drug-Eluting Stents Basic Information
9.8.2 Biosensors International Drug-Eluting Stents Product Overview
9.8.3 Biosensors International Drug-Eluting Stents Product Market Performance
9.8.4 Biosensors International Business Overview
9.8.5 Biosensors International Recent Developments
9.9 Balton
9.9.1 Balton Drug-Eluting Stents Basic Information
9.9.2 Balton Drug-Eluting Stents Product Overview
9.9.3 Balton Drug-Eluting Stents Product Market Performance
9.9.4 Balton Business Overview
9.9.5 Balton Recent Developments
9.10 AlviMedica Medical Technologies
9.10.1 AlviMedica Medical Technologies Drug-Eluting Stents Basic Information
9.10.2 AlviMedica Medical Technologies Drug-Eluting Stents Product Overview
9.10.3 AlviMedica Medical Technologies Drug-Eluting Stents Product Market Performance
9.10.4 AlviMedica Medical Technologies Business Overview
9.10.5 AlviMedica Medical Technologies Recent Developments
9.11 Biotronik
9.11.1 Biotronik Drug-Eluting Stents Basic Information
9.11.2 Biotronik Drug-Eluting Stents Product Overview
9.11.3 Biotronik Drug-Eluting Stents Product Market Performance
9.11.4 Biotronik Business Overview
9.11.5 Biotronik Recent Developments
9.12 Shandong JW Medical
9.12.1 Shandong JW Medical Drug-Eluting Stents Basic Information
9.12.2 Shandong JW Medical Drug-Eluting Stents Product Overview
9.12.3 Shandong JW Medical Drug-Eluting Stents Product Market Performance
9.12.4 Shandong JW Medical Business Overview
9.12.5 Shandong JW Medical Recent Developments
9.13 Sino Medical
9.13.1 Sino Medical Drug-Eluting Stents Basic Information
9.13.2 Sino Medical Drug-Eluting Stents Product Overview
9.13.3 Sino Medical Drug-Eluting Stents Product Market Performance
9.13.4 Sino Medical Business Overview
9.13.5 Sino Medical Recent Developments
9.14 Beijing AMSINO
9.14.1 Beijing AMSINO Drug-Eluting Stents Basic Information
9.14.2 Beijing AMSINO Drug-Eluting Stents Product Overview
9.14.3 Beijing AMSINO Drug-Eluting Stents Product Market Performance
9.14.4 Beijing AMSINO Business Overview
9.14.5 Beijing AMSINO Recent Developments
9.15 Liaoning Biomedical Materials RandD Center Co.(LBC)
9.15.1 Liaoning Biomedical Materials RandD Center Co.(LBC) Drug-Eluting Stents Basic Information
9.15.2 Liaoning Biomedical Materials RandD Center Co.(LBC) Drug-Eluting Stents Product Overview
9.15.3 Liaoning Biomedical Materials RandD Center Co.(LBC) Drug-Eluting Stents Product Market Performance
9.15.4 Liaoning Biomedical Materials RandD Center Co.(LBC) Business Overview
9.15.5 Liaoning Biomedical Materials RandD Center Co.(LBC) Recent Developments
10 DRUG-ELUTING STENTS MARKET FORECAST BY REGION
10.1 Global Drug-Eluting Stents Market Size Forecast
10.2 Global Drug-Eluting Stents Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Drug-Eluting Stents Market Size Forecast by Country
10.2.3 Asia Pacific Drug-Eluting Stents Market Size Forecast by Region
10.2.4 South America Drug-Eluting Stents Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Drug-Eluting Stents by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Drug-Eluting Stents Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Drug-Eluting Stents by Type (2025-2030)
11.1.2 Global Drug-Eluting Stents Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Drug-Eluting Stents by Type (2025-2030)
11.2 Global Drug-Eluting Stents Market Forecast by Application (2025-2030)
11.2.1 Global Drug-Eluting Stents Sales (K Units) Forecast by Application
11.2.2 Global Drug-Eluting Stents Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drug-Eluting Stents Market Size Comparison by Region (M USD)
Table 5. Global Drug-Eluting Stents Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Drug-Eluting Stents Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Drug-Eluting Stents Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Drug-Eluting Stents Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Eluting Stents as of 2022)
Table 10. Global Market Drug-Eluting Stents Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Drug-Eluting Stents Sales Sites and Area Served
Table 12. Manufacturers Drug-Eluting Stents Product Type
Table 13. Global Drug-Eluting Stents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Drug-Eluting Stents
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Drug-Eluting Stents Market Challenges
Table 22. Global Drug-Eluting Stents Sales by Type (K Units)
Table 23. Global Drug-Eluting Stents Market Size by Type (M USD)
Table 24. Global Drug-Eluting Stents Sales (K Units) by Type (2019-2024)
Table 25. Global Drug-Eluting Stents Sales Market Share by Type (2019-2024)
Table 26. Global Drug-Eluting Stents Market Size (M USD) by Type (2019-2024)
Table 27. Global Drug-Eluting Stents Market Size Share by Type (2019-2024)
Table 28. Global Drug-Eluting Stents Price (USD/Unit) by Type (2019-2024)
Table 29. Global Drug-Eluting Stents Sales (K Units) by Application
Table 30. Global Drug-Eluting Stents Market Size by Application
Table 31. Global Drug-Eluting Stents Sales by Application (2019-2024) & (K Units)
Table 32. Global Drug-Eluting Stents Sales Market Share by Application (2019-2024)
Table 33. Global Drug-Eluting Stents Sales by Application (2019-2024) & (M USD)
Table 34. Global Drug-Eluting Stents Market Share by Application (2019-2024)
Table 35. Global Drug-Eluting Stents Sales Growth Rate by Application (2019-2024)
Table 36. Global Drug-Eluting Stents Sales by Region (2019-2024) & (K Units)
Table 37. Global Drug-Eluting Stents Sales Market Share by Region (2019-2024)
Table 38. North America Drug-Eluting Stents Sales by Country (2019-2024) & (K Units)
Table 39. Europe Drug-Eluting Stents Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Drug-Eluting Stents Sales by Region (2019-2024) & (K Units)
Table 41. South America Drug-Eluting Stents Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Drug-Eluting Stents Sales by Region (2019-2024) & (K Units)
Table 43. Boston Scientific Drug-Eluting Stents Basic Information
Table 44. Boston Scientific Drug-Eluting Stents Product Overview
Table 45. Boston Scientific Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Boston Scientific Business Overview
Table 47. Boston Scientific Drug-Eluting Stents SWOT Analysis
Table 48. Boston Scientific Recent Developments
Table 49. Medtronic, Inc. Drug-Eluting Stents Basic Information
Table 50. Medtronic, Inc. Drug-Eluting Stents Product Overview
Table 51. Medtronic, Inc. Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Medtronic, Inc. Business Overview
Table 53. Medtronic, Inc. Drug-Eluting Stents SWOT Analysis
Table 54. Medtronic, Inc. Recent Developments
Table 55. Abbott Drug-Eluting Stents Basic Information
Table 56. Abbott Drug-Eluting Stents Product Overview
Table 57. Abbott Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Abbott Drug-Eluting Stents SWOT Analysis
Table 59. Abbott Business Overview
Table 60. Abbott Recent Developments
Table 61. Lepu Medical Drug-Eluting Stents Basic Information
Table 62. Lepu Medical Drug-Eluting Stents Product Overview
Table 63. Lepu Medical Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Lepu Medical Business Overview
Table 65. Lepu Medical Recent Developments
Table 66. MicroPort Scientific Corporation Drug-Eluting Stents Basic Information
Table 67. MicroPort Scientific Corporation Drug-Eluting Stents Product Overview
Table 68. MicroPort Scientific Corporation Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. MicroPort Scientific Corporation Business Overview
Table 70. MicroPort Scientific Corporation Recent Developments
Table 71. Cook Medical Drug-Eluting Stents Basic Information
Table 72. Cook Medical Drug-Eluting Stents Product Overview
Table 73. Cook Medical Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Cook Medical Business Overview
Table 75. Cook Medical Recent Developments
Table 76. Terumo Drug-Eluting Stents Basic Information
Table 77. Terumo Drug-Eluting Stents Product Overview
Table 78. Terumo Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Terumo Business Overview
Table 80. Terumo Recent Developments
Table 81. Biosensors International Drug-Eluting Stents Basic Information
Table 82. Biosensors International Drug-Eluting Stents Product Overview
Table 83. Biosensors International Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Biosensors International Business Overview
Table 85. Biosensors International Recent Developments
Table 86. Balton Drug-Eluting Stents Basic Information
Table 87. Balton Drug-Eluting Stents Product Overview
Table 88. Balton Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Balton Business Overview
Table 90. Balton Recent Developments
Table 91. AlviMedica Medical Technologies Drug-Eluting Stents Basic Information
Table 92. AlviMedica Medical Technologies Drug-Eluting Stents Product Overview
Table 93. AlviMedica Medical Technologies Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. AlviMedica Medical Technologies Business Overview
Table 95. AlviMedica Medical Technologies Recent Developments
Table 96. Biotronik Drug-Eluting Stents Basic Information
Table 97. Biotronik Drug-Eluting Stents Product Overview
Table 98. Biotronik Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Biotronik Business Overview
Table 100. Biotronik Recent Developments
Table 101. Shandong JW Medical Drug-Eluting Stents Basic Information
Table 102. Shandong JW Medical Drug-Eluting Stents Product Overview
Table 103. Shandong JW Medical Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Shandong JW Medical Business Overview
Table 105. Shandong JW Medical Recent Developments
Table 106. Sino Medical Drug-Eluting Stents Basic Information
Table 107. Sino Medical Drug-Eluting Stents Product Overview
Table 108. Sino Medical Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Sino Medical Business Overview
Table 110. Sino Medical Recent Developments
Table 111. Beijing AMSINO Drug-Eluting Stents Basic Information
Table 112. Beijing AMSINO Drug-Eluting Stents Product Overview
Table 113. Beijing AMSINO Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Beijing AMSINO Business Overview
Table 115. Beijing AMSINO Recent Developments
Table 116. Liaoning Biomedical Materials RandD Center Co.(LBC) Drug-Eluting Stents Basic Information
Table 117. Liaoning Biomedical Materials RandD Center Co.(LBC) Drug-Eluting Stents Product Overview
Table 118. Liaoning Biomedical Materials RandD Center Co.(LBC) Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Liaoning Biomedical Materials RandD Center Co.(LBC) Business Overview
Table 120. Liaoning Biomedical Materials RandD Center Co.(LBC) Recent Developments
Table 121. Global Drug-Eluting Stents Sales Forecast by Region (2025-2030) & (K Units)
Table 122. Global Drug-Eluting Stents Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Drug-Eluting Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 124. North America Drug-Eluting Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Drug-Eluting Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 126. Europe Drug-Eluting Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Drug-Eluting Stents Sales Forecast by Region (2025-2030) & (K Units)
Table 128. Asia Pacific Drug-Eluting Stents Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Drug-Eluting Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 130. South America Drug-Eluting Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Drug-Eluting Stents Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Drug-Eluting Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Drug-Eluting Stents Sales Forecast by Type (2025-2030) & (K Units)
Table 134. Global Drug-Eluting Stents Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Drug-Eluting Stents Price Forecast by Type (2025-2030) & (USD/Unit)
Table 136. Global Drug-Eluting Stents Sales (K Units) Forecast by Application (2025-2030)
Table 137. Global Drug-Eluting Stents Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drug-Eluting Stents Market Size Comparison by Region (M USD)
Table 5. Global Drug-Eluting Stents Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Drug-Eluting Stents Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Drug-Eluting Stents Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Drug-Eluting Stents Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Eluting Stents as of 2022)
Table 10. Global Market Drug-Eluting Stents Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Drug-Eluting Stents Sales Sites and Area Served
Table 12. Manufacturers Drug-Eluting Stents Product Type
Table 13. Global Drug-Eluting Stents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Drug-Eluting Stents
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Drug-Eluting Stents Market Challenges
Table 22. Global Drug-Eluting Stents Sales by Type (K Units)
Table 23. Global Drug-Eluting Stents Market Size by Type (M USD)
Table 24. Global Drug-Eluting Stents Sales (K Units) by Type (2019-2024)
Table 25. Global Drug-Eluting Stents Sales Market Share by Type (2019-2024)
Table 26. Global Drug-Eluting Stents Market Size (M USD) by Type (2019-2024)
Table 27. Global Drug-Eluting Stents Market Size Share by Type (2019-2024)
Table 28. Global Drug-Eluting Stents Price (USD/Unit) by Type (2019-2024)
Table 29. Global Drug-Eluting Stents Sales (K Units) by Application
Table 30. Global Drug-Eluting Stents Market Size by Application
Table 31. Global Drug-Eluting Stents Sales by Application (2019-2024) & (K Units)
Table 32. Global Drug-Eluting Stents Sales Market Share by Application (2019-2024)
Table 33. Global Drug-Eluting Stents Sales by Application (2019-2024) & (M USD)
Table 34. Global Drug-Eluting Stents Market Share by Application (2019-2024)
Table 35. Global Drug-Eluting Stents Sales Growth Rate by Application (2019-2024)
Table 36. Global Drug-Eluting Stents Sales by Region (2019-2024) & (K Units)
Table 37. Global Drug-Eluting Stents Sales Market Share by Region (2019-2024)
Table 38. North America Drug-Eluting Stents Sales by Country (2019-2024) & (K Units)
Table 39. Europe Drug-Eluting Stents Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Drug-Eluting Stents Sales by Region (2019-2024) & (K Units)
Table 41. South America Drug-Eluting Stents Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Drug-Eluting Stents Sales by Region (2019-2024) & (K Units)
Table 43. Boston Scientific Drug-Eluting Stents Basic Information
Table 44. Boston Scientific Drug-Eluting Stents Product Overview
Table 45. Boston Scientific Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Boston Scientific Business Overview
Table 47. Boston Scientific Drug-Eluting Stents SWOT Analysis
Table 48. Boston Scientific Recent Developments
Table 49. Medtronic, Inc. Drug-Eluting Stents Basic Information
Table 50. Medtronic, Inc. Drug-Eluting Stents Product Overview
Table 51. Medtronic, Inc. Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Medtronic, Inc. Business Overview
Table 53. Medtronic, Inc. Drug-Eluting Stents SWOT Analysis
Table 54. Medtronic, Inc. Recent Developments
Table 55. Abbott Drug-Eluting Stents Basic Information
Table 56. Abbott Drug-Eluting Stents Product Overview
Table 57. Abbott Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Abbott Drug-Eluting Stents SWOT Analysis
Table 59. Abbott Business Overview
Table 60. Abbott Recent Developments
Table 61. Lepu Medical Drug-Eluting Stents Basic Information
Table 62. Lepu Medical Drug-Eluting Stents Product Overview
Table 63. Lepu Medical Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Lepu Medical Business Overview
Table 65. Lepu Medical Recent Developments
Table 66. MicroPort Scientific Corporation Drug-Eluting Stents Basic Information
Table 67. MicroPort Scientific Corporation Drug-Eluting Stents Product Overview
Table 68. MicroPort Scientific Corporation Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. MicroPort Scientific Corporation Business Overview
Table 70. MicroPort Scientific Corporation Recent Developments
Table 71. Cook Medical Drug-Eluting Stents Basic Information
Table 72. Cook Medical Drug-Eluting Stents Product Overview
Table 73. Cook Medical Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Cook Medical Business Overview
Table 75. Cook Medical Recent Developments
Table 76. Terumo Drug-Eluting Stents Basic Information
Table 77. Terumo Drug-Eluting Stents Product Overview
Table 78. Terumo Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Terumo Business Overview
Table 80. Terumo Recent Developments
Table 81. Biosensors International Drug-Eluting Stents Basic Information
Table 82. Biosensors International Drug-Eluting Stents Product Overview
Table 83. Biosensors International Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Biosensors International Business Overview
Table 85. Biosensors International Recent Developments
Table 86. Balton Drug-Eluting Stents Basic Information
Table 87. Balton Drug-Eluting Stents Product Overview
Table 88. Balton Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Balton Business Overview
Table 90. Balton Recent Developments
Table 91. AlviMedica Medical Technologies Drug-Eluting Stents Basic Information
Table 92. AlviMedica Medical Technologies Drug-Eluting Stents Product Overview
Table 93. AlviMedica Medical Technologies Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. AlviMedica Medical Technologies Business Overview
Table 95. AlviMedica Medical Technologies Recent Developments
Table 96. Biotronik Drug-Eluting Stents Basic Information
Table 97. Biotronik Drug-Eluting Stents Product Overview
Table 98. Biotronik Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Biotronik Business Overview
Table 100. Biotronik Recent Developments
Table 101. Shandong JW Medical Drug-Eluting Stents Basic Information
Table 102. Shandong JW Medical Drug-Eluting Stents Product Overview
Table 103. Shandong JW Medical Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Shandong JW Medical Business Overview
Table 105. Shandong JW Medical Recent Developments
Table 106. Sino Medical Drug-Eluting Stents Basic Information
Table 107. Sino Medical Drug-Eluting Stents Product Overview
Table 108. Sino Medical Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Sino Medical Business Overview
Table 110. Sino Medical Recent Developments
Table 111. Beijing AMSINO Drug-Eluting Stents Basic Information
Table 112. Beijing AMSINO Drug-Eluting Stents Product Overview
Table 113. Beijing AMSINO Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Beijing AMSINO Business Overview
Table 115. Beijing AMSINO Recent Developments
Table 116. Liaoning Biomedical Materials RandD Center Co.(LBC) Drug-Eluting Stents Basic Information
Table 117. Liaoning Biomedical Materials RandD Center Co.(LBC) Drug-Eluting Stents Product Overview
Table 118. Liaoning Biomedical Materials RandD Center Co.(LBC) Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Liaoning Biomedical Materials RandD Center Co.(LBC) Business Overview
Table 120. Liaoning Biomedical Materials RandD Center Co.(LBC) Recent Developments
Table 121. Global Drug-Eluting Stents Sales Forecast by Region (2025-2030) & (K Units)
Table 122. Global Drug-Eluting Stents Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Drug-Eluting Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 124. North America Drug-Eluting Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Drug-Eluting Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 126. Europe Drug-Eluting Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Drug-Eluting Stents Sales Forecast by Region (2025-2030) & (K Units)
Table 128. Asia Pacific Drug-Eluting Stents Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Drug-Eluting Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 130. South America Drug-Eluting Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Drug-Eluting Stents Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Drug-Eluting Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Drug-Eluting Stents Sales Forecast by Type (2025-2030) & (K Units)
Table 134. Global Drug-Eluting Stents Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Drug-Eluting Stents Price Forecast by Type (2025-2030) & (USD/Unit)
Table 136. Global Drug-Eluting Stents Sales (K Units) Forecast by Application (2025-2030)
Table 137. Global Drug-Eluting Stents Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Drug-Eluting Stents
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug-Eluting Stents Market Size (M USD), 2019-2030
Figure 5. Global Drug-Eluting Stents Market Size (M USD) (2019-2030)
Figure 6. Global Drug-Eluting Stents Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drug-Eluting Stents Market Size by Country (M USD)
Figure 11. Drug-Eluting Stents Sales Share by Manufacturers in 2023
Figure 12. Global Drug-Eluting Stents Revenue Share by Manufacturers in 2023
Figure 13. Drug-Eluting Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Drug-Eluting Stents Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Drug-Eluting Stents Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Drug-Eluting Stents Market Share by Type
Figure 18. Sales Market Share of Drug-Eluting Stents by Type (2019-2024)
Figure 19. Sales Market Share of Drug-Eluting Stents by Type in 2023
Figure 20. Market Size Share of Drug-Eluting Stents by Type (2019-2024)
Figure 21. Market Size Market Share of Drug-Eluting Stents by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Drug-Eluting Stents Market Share by Application
Figure 24. Global Drug-Eluting Stents Sales Market Share by Application (2019-2024)
Figure 25. Global Drug-Eluting Stents Sales Market Share by Application in 2023
Figure 26. Global Drug-Eluting Stents Market Share by Application (2019-2024)
Figure 27. Global Drug-Eluting Stents Market Share by Application in 2023
Figure 28. Global Drug-Eluting Stents Sales Growth Rate by Application (2019-2024)
Figure 29. Global Drug-Eluting Stents Sales Market Share by Region (2019-2024)
Figure 30. North America Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Drug-Eluting Stents Sales Market Share by Country in 2023
Figure 32. U.S. Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Drug-Eluting Stents Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Drug-Eluting Stents Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Drug-Eluting Stents Sales Market Share by Country in 2023
Figure 37. Germany Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Drug-Eluting Stents Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Drug-Eluting Stents Sales Market Share by Region in 2023
Figure 44. China Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Drug-Eluting Stents Sales and Growth Rate (K Units)
Figure 50. South America Drug-Eluting Stents Sales Market Share by Country in 2023
Figure 51. Brazil Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Drug-Eluting Stents Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Drug-Eluting Stents Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Drug-Eluting Stents Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Drug-Eluting Stents Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Drug-Eluting Stents Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Drug-Eluting Stents Market Share Forecast by Type (2025-2030)
Figure 65. Global Drug-Eluting Stents Sales Forecast by Application (2025-2030)
Figure 66. Global Drug-Eluting Stents Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Drug-Eluting Stents
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug-Eluting Stents Market Size (M USD), 2019-2030
Figure 5. Global Drug-Eluting Stents Market Size (M USD) (2019-2030)
Figure 6. Global Drug-Eluting Stents Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drug-Eluting Stents Market Size by Country (M USD)
Figure 11. Drug-Eluting Stents Sales Share by Manufacturers in 2023
Figure 12. Global Drug-Eluting Stents Revenue Share by Manufacturers in 2023
Figure 13. Drug-Eluting Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Drug-Eluting Stents Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Drug-Eluting Stents Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Drug-Eluting Stents Market Share by Type
Figure 18. Sales Market Share of Drug-Eluting Stents by Type (2019-2024)
Figure 19. Sales Market Share of Drug-Eluting Stents by Type in 2023
Figure 20. Market Size Share of Drug-Eluting Stents by Type (2019-2024)
Figure 21. Market Size Market Share of Drug-Eluting Stents by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Drug-Eluting Stents Market Share by Application
Figure 24. Global Drug-Eluting Stents Sales Market Share by Application (2019-2024)
Figure 25. Global Drug-Eluting Stents Sales Market Share by Application in 2023
Figure 26. Global Drug-Eluting Stents Market Share by Application (2019-2024)
Figure 27. Global Drug-Eluting Stents Market Share by Application in 2023
Figure 28. Global Drug-Eluting Stents Sales Growth Rate by Application (2019-2024)
Figure 29. Global Drug-Eluting Stents Sales Market Share by Region (2019-2024)
Figure 30. North America Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Drug-Eluting Stents Sales Market Share by Country in 2023
Figure 32. U.S. Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Drug-Eluting Stents Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Drug-Eluting Stents Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Drug-Eluting Stents Sales Market Share by Country in 2023
Figure 37. Germany Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Drug-Eluting Stents Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Drug-Eluting Stents Sales Market Share by Region in 2023
Figure 44. China Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Drug-Eluting Stents Sales and Growth Rate (K Units)
Figure 50. South America Drug-Eluting Stents Sales Market Share by Country in 2023
Figure 51. Brazil Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Drug-Eluting Stents Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Drug-Eluting Stents Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Drug-Eluting Stents Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Drug-Eluting Stents Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Drug-Eluting Stents Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Drug-Eluting Stents Market Share Forecast by Type (2025-2030)
Figure 65. Global Drug-Eluting Stents Sales Forecast by Application (2025-2030)
Figure 66. Global Drug-Eluting Stents Market Share Forecast by Application (2025-2030)
